Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events

被引:58
作者
Brieger, D. [1 ]
Fox, K. A. A. [8 ]
FitzGerald, G. [7 ]
Eagle, K. A. [6 ]
Budaj, A. [5 ]
Avezum, A. [4 ]
Granger, C. B. [2 ]
Costa, B. [1 ]
Anderson, F. A., Jr. [7 ]
Steg, Ph G. [3 ]
机构
[1] Concord Hosp, Coronary Care Unit, Sydney, NSW, Australia
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Univ Paris 07, INSERM, Dept Cardiol, AP HP,U698, Paris, France
[4] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil
[5] Grochowski Hosp, Dept Cardiol, Postgrad Med Sch, Warsaw, Poland
[6] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[7] Univ Massachusetts, Sch Med, Ctr Outcomes Res, Worcester, MA USA
[8] Univ Edinburgh, Div Med & Radiol Sci, Edinburgh, Midlothian, Scotland
关键词
TIMI RISK SCORE; HOSPITAL OUTCOMES; CHEST-PAIN; MANAGEMENT; MORTALITY; THERAPY; IMPACT; MODEL;
D O I
10.1136/hrt.2008.153387
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) with a low likelihood of any adverse in-hospital event. Design, setting and patients: Data were analysed from 24 097 patients with NSTEMI or unstable angina included in the Global Registry of Acute Coronary Events (January 2001 to September 2007). Main outcome measures: In-hospital events were myocardial infarction, arrhythmia, congestive heart failure or shock, major bleeding, stroke or death. Two-thirds of the patients were randomly chosen for model development and the remainder for model validation. Multiple logistic regression identified predictors of freedom from an in-hospital event, and a Freedom-from-Event score was developed. Results: Of the 16 127 patients in the model development group, 19.1% experienced an in-hospital adverse event. Fifteen factors independently predicted freedom from an adverse event: younger age; lower Killip class; unstable angina presentation; no hypotension; no ST deviation; no cardiac arrest at presentation; normal creatinine; decreased pulse rate; no hospital transfer; no history of diabetes, heart failure, peripheral arterial disease, or atrial fibrillation; prehospital use of statins, and no chronic warfarin. In the validation group, 18.6% experienced an adverse event. The model discriminated well between patients experiencing an in-hospital event and those who did not in both derivation and validation groups (c-statistic = 0.77 in both). Patients in the three lowest risk deciles had a very low in-hospital mortality (<0.5%) and an uncomplicated clinical course (>93% event-free in hospital). The model also predicted freedom from postdischarge events (death, myocardial infarction, stroke; c-statistic = 0.77). Conclusions: The GRACE Freedom-from-Event score can predict the in-hospital course of NSTE-ACS, and identifies up to 30% of the admitted population at low risk of death or any adverse in-hospital event.
引用
收藏
页码:888 / 894
页数:7
相关论文
共 30 条
[1]   Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project:: A multinational registry of patients hospitalized with acute coronary syndromes [J].
Agnelli, G ;
Avezum, A ;
Brieger, D ;
Budaj, A ;
Cannon, CP ;
Goldberg, RJ ;
Goodman, S ;
Gulba, DC ;
Granger, C ;
Kennelly, BM ;
Gurfinkel, E ;
López-Sendón, J ;
Klein, W ;
Montalescot, G ;
Van de Werf, F .
AMERICAN HEART JOURNAL, 2001, 141 (02) :190-199
[2]   ACC/AHA 2007 Guidelines for the Management of Patients With unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine [J].
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Antman, Elliott M. ;
Bridges, Charles R. ;
Califf, Robert M. ;
Casey, Donald E., Jr. ;
Chavey, William E. ;
Fesmire, Francis M. ;
Hochman, Judith S. ;
Levin, Thomas N. ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Theroux, Pierre ;
Wenger, Nanette Kass ;
Wright, R. Scott ;
Smith, Sidney C. ;
Jacobs, Alice K. ;
Halperin, Jonathan L. ;
Hunt, Sharon A. ;
Krumholz, Harlan M. ;
Kushner, Frederick G. ;
Lytle, Bruce W. ;
Nishimura, Rick ;
Ornato, Joseph P. ;
Page, Richard L. ;
Riegel, Barbara .
CIRCULATION, 2007, 116 (07) :E148-E304
[3]   The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making [J].
Antman, EM ;
Cohen, M ;
Bernink, PJLM ;
McCabe, CH ;
Horacek, T ;
Papuchis, G ;
Mautner, B ;
Corbalan, R ;
Radley, D ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07) :835-842
[4]   Incidence and prognosis of ventricular, tachycardia and ventricular fibrillation after non-ST elevation acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events [J].
Avezum, A ;
Knobel, M ;
Goldberg, RJ ;
Sadiq, I ;
Saperia, G ;
Smyth, T ;
Paoloni, R ;
Brieger, D ;
Kuznetsova, P ;
Gore, JM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :116A-116A
[5]  
Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161
[6]   Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [J].
Bertrand, ME ;
Simoons, ML ;
Fox, KAA ;
Wallentin, LC ;
Hamm, CW ;
McFadden, E ;
De Feyter, PJ ;
Specchia, G ;
Ruzyllo, W .
EUROPEAN HEART JOURNAL, 2002, 23 (23) :1809-1840
[7]   Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients [J].
Boersma, E ;
Pieper, KS ;
Steyerberg, EW ;
Wilcox, RG ;
Chang, WC ;
Lee, KL ;
Akkerhuis, KM ;
Harrington, RA ;
Deckers, JW ;
Armstrong, PW ;
Lincoff, AM ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
CIRCULATION, 2000, 101 (22) :2557-2567
[8]   Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials [J].
Boersma, E ;
Harrington, RA ;
Moliterno, DJ ;
White, H ;
Théroux, P ;
Van de Werf, F ;
de Torbal, A ;
Armstrong, PW ;
Wallentin, LC ;
Wilcox, RG ;
Simes, J ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
LANCET, 2002, 359 (9302) :189-198
[9]   Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes - Findings from a global registry of acute coronary events [J].
Budaj, A ;
Flasinska, K ;
Gore, JM ;
Anderson, FA ;
Dabbous, OH ;
Spencer, FA ;
Goldberg, RJ ;
Fox, KAA .
CIRCULATION, 2005, 111 (24) :3242-3247
[10]   Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure [J].
Bunch, TJ ;
Muhlestein, JB ;
Bair, TL ;
Renlund, DG ;
Lappé, DL ;
Jensen, KR ;
Horne, BD ;
Carter, MA ;
Anderson, JL .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (07) :827-831